Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Executive VP and CFO of H.B. Fuller, John J. Corkrean, filed a Form 4 detailing changes in beneficial ownership, including the acquisition of phantom units and adjustments to stock options and restricted stock units.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller, reported changes in beneficial ownership of the company's stock.
- The report details the acquisition of 98.47 phantom units on March 15, 2024, at a price of $79.66.
- Corkrean directly owns 47,187 shares of common stock.
- The report also includes information on employee stock options and restricted stock units, including vesting schedules and expiration dates.
- Several employee stock options are 100% vested.
- Restricted stock units convert into common stock on a 1-for-1 basis and vest in three annual installments.
- The reporting person has various employee stock options with exercise prices ranging from $43.48 to $77.72 and expiration dates between 2026 and 2034.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing. The sentiment is neutral as it simply reports transactions. The executive's continued holdings and acquisitions are a mildly positive signal.
Positives
- The reporting person holds a significant number of shares and stock options, indicating alignment with the company's success.
- The vesting schedules of stock options and restricted stock units incentivize long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, restricted stock units, and other incentives.
- The vesting schedules and exercise prices of stock options are generally designed to align executive interests with shareholder value creation.
- Companies like Sherwin-Williams and PPG Industries, which are also in the specialty chemicals industry, have similar executive compensation structures.
Stakeholder Impact
- Shareholders may view the transactions as an indication of management's confidence in the company.
- Employees holding stock options and restricted stock units are directly impacted by the vesting schedules and stock price.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of employee stock option (Right-to-Buy) exercisable, expiring 05/17/2026, at $43.48. |
| 01/26/2018 | Date of employee stock option (Right-to-Buy) exercisable, expiring 01/26/2027, at $50.1. |
| 01/25/2019 | Date of employee stock option (Right-to-Buy) exercisable, expiring 01/25/2028, at $53.57. |
| 01/24/2020 | Date of employee stock option (Right-to-Buy) exercisable, expiring 01/24/2029, at $45.05. |
| 01/24/2021 | Date of employee stock option (Right-to-Buy) exercisable, expiring 01/24/2030, at $48.35. |
| 01/27/2022 | Date of employee stock option (Right-to-Buy) exercisable, expiring 01/27/2031, at $51.89. |
| 01/24/2023 | Date of employee stock option (Right-to-Buy) exercisable, expiring 01/24/2032, at $72.94 and restricted stock units vesting, expiring 01/24/2025. |
| 01/24/2024 | Date of employee stock option (Right-to-Buy) exercisable, expiring 01/24/2033, at $68.17 and restricted stock units vesting, expiring 01/24/2026. |
| 01/26/2025 | Date of employee stock option (Right-to-Buy) exercisable, expiring 01/26/2034, at $77.72 and restricted stock units vesting, expiring 01/26/2027. |
| 03/15/2024 | Date of transaction: acquisition of 98.47 phantom units. |
| 03/18/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.